Bluejay Diagnostics Inc
Research Bluejay Diagnostics Inc (BJDX) on Bullrun: market cap USD 947.79K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBJDX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 947.79K
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 1.92M
- Free cash flow-USD 6.65M
Valuation Snapshot
latest market cap is USD 947.79K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 6.85M | -USD 6.23M | n/a | -15.25 | USD 5.16M | USD 120.21K | USD 5.98M |
| FY2024 | USD 0 | -USD 7.72M | -USD 8.13M | n/a | -456.75 | USD 4.30M | USD 222.25K | USD 5.73M |
| FY2023 | n/a | -USD 9.95M | -USD 9.02M | n/a | -3631.48 | USD 2.21M | USD 352.98K | USD 2.89M |
| FY2022 | USD 249.04K | -USD 9.30M | -USD 8.94M | 19.6% | -9.22 | USD 10.11M | USD 430.12K | USD 11.54M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 947.79K | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.61M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.70M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.56M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 7.30M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 49.15M | n/a | n/a | n/a |
About Bluejay Diagnostics Inc
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bluejay Diagnostics Inc's market cap?
Bluejay Diagnostics Inc's market capitalization is USD 947.79K.
What does Bluejay Diagnostics Inc do?
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings.